Company News: Page (1) of 1 - 08/03/17 Email this story to a friend. email article Print this page (Article printing at page facebook

Synthetic Biologics Reports Second Quarter 2017 Operational Highlights and Financial Results

-- SYN-004 (ribaxamase) Receives Breakthrough Therapy Designation from FDA for Prevention of CDI ---- Three Ribaxamase Presentations to be Included at Infectious Disease Week™ (ID Week) 2017 ---- Conf... (August 03, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Pro AV,Management,Presentors,Internet/Web,Internet,Webcasting,Business Issues,Internet Media,Presentation,Marketing,Events, webcast,USA, Inc.,Medicine,Disease,Pregnancy,Surgery,Pregnancy,Science,Lifestyle,Internet Technology,Medical,Biology,Genetics,
Related Sites: Digital Producer ,   Digital Webcast ,   Presentation Master ,   Oceania ,   DMN Newswire ,   BN - Webcast ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: DMN Newsletter ,   CMN Newsletter ,   Streamline Newsletter ,   KNews Newsletter ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved